Skip to main content
See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $155.00

Summary by marketbeat.com
UBS Group increased their target price on shares of Gilead Sciences from $145.00 to $155.00 and gave the company a "buy" rating in a research report on Monday.

2 Articles

marketbeat.commarketbeat.com
Reposted by
themarketsdaily.comthemarketsdaily.com
Center

Gilead Sciences (NASDAQ:GILD) Price Target Raised to $155.00

UBS Group increased their target price on shares of Gilead Sciences from $145.00 to $155.00 and gave the company a "buy" rating in a research report on Monday.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

marketbeat.com broke the news in on Monday, January 26, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Gilead Sciences icon

Gilead Sciences

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal